194 related articles for article (PubMed ID: 24085323)
1. In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Roomi MW; Kalinovsky T; Monterrey J; Rath M; Niedzwiecki A
Int J Oncol; 2013 Dec; 43(6):1787-98. PubMed ID: 24085323
[TBL] [Abstract][Full Text] [Related]
2. Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2017 Mar; 37(3):1907-1913. PubMed ID: 28112361
[TBL] [Abstract][Full Text] [Related]
3. In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Int J Oncol; 2014 Jan; 44(1):27-34. PubMed ID: 24190483
[TBL] [Abstract][Full Text] [Related]
4. Cytokines, inducers and inhibitors modulate MMP-2 and MMP‑9 secretion by human Fanconi anemia immortalized fibroblasts.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2017 Mar; 37(3):1842-1848. PubMed ID: 28098879
[TBL] [Abstract][Full Text] [Related]
5. In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2010 Mar; 23(3):605-14. PubMed ID: 20126997
[TBL] [Abstract][Full Text] [Related]
6. Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2017 Jun; 37(6):3681-3687. PubMed ID: 28440509
[TBL] [Abstract][Full Text] [Related]
7. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Jul; 43(1):39-49. PubMed ID: 23661254
[TBL] [Abstract][Full Text] [Related]
8. Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2006; 23(2):245-50. PubMed ID: 16720925
[TBL] [Abstract][Full Text] [Related]
9. Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2009 Dec; 22(6):1283-91. PubMed ID: 19885578
[TBL] [Abstract][Full Text] [Related]
10. Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.
Harati K; Behr B; Wallner C; Daigeler A; Hirsch T; Jacobsen F; Renner M; Harati A; Lehnhardt M; Becerikli M
Mol Med Rep; 2017 Jan; 15(1):103-110. PubMed ID: 27909727
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2010 Sep; 24(3):747-57. PubMed ID: 20664983
[TBL] [Abstract][Full Text] [Related]
12. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Oct; 43(4):1027-35. PubMed ID: 23900236
[TBL] [Abstract][Full Text] [Related]
13. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
[TBL] [Abstract][Full Text] [Related]
14. Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.
Rodriques M; Chehne F; Kalinowska W; Zielinski C; Sinzinger H
Eur J Nucl Med; 2000 Dec; 27(12):1839-43. PubMed ID: 11189948
[TBL] [Abstract][Full Text] [Related]
15. Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Int J Oncol; 2014 Mar; 44(3):986-92. PubMed ID: 24378964
[TBL] [Abstract][Full Text] [Related]
16. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
17. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.
Lohi J; Lehti K; Westermarck J; Kähäri VM; Keski-Oja J
Eur J Biochem; 1996 Jul; 239(2):239-47. PubMed ID: 8706726
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cell invasion and MMP production by a nutrient mixture in malignant liposarcoma cell line SW-872.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2007; 24(4):394-401. PubMed ID: 17917088
[TBL] [Abstract][Full Text] [Related]
19. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β.
Kim BJ; Hur JW; Park JS; Kim JH; Kwon TH; Park YK; Moon HJ
J Neurosurg Spine; 2016 Mar; 24(3):428-35. PubMed ID: 26565765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
